The department of Healthcare & Life-Sciences at Gross & Co. has over 30 years of experience in representing clients from a wide array of business and technological sectors, such as -biotechnology, pharmaceuticals, medical devices, diagnostics, health IT, mobile health, cosmetics, food, agriculture – including medical cannabis, marine biology and veterinary, among others.
The team has vast knowledge regarding local rules and regulations, as well as standard practices that apply to the ownership, licensing, clinical trials, use and transfer of technologies (including technologies originating in Israeli universities, hospitals, and the IDF), marketing, and sale of life sciences products – Thus positioned at the forefront of the Israeli Life Sciences legal practice.
The team has an in-depth understanding of the highly regulated nature of Israel’s health industry. They expertly represent clients and oversee transactions in a complex field characterized by frequent regulatory changes.
The legal team advises clients in all product life cycle stages, from licensing and early research & development through clinical phases, manufacture, commercialization, marketing & sales, and more.
The department’s clients are companies in various stages of development – ranging from seed stage start-ups to well-established global companies. The latter is subject to the greater complexity of legal frameworks. In addition, the department handles international investment banks, private investors and other financial institutions, venture capital funds, and lenders, which are involved in collaborations and financing activities based on life sciences and biotechnology.
